Cell therapy Archives

In Depth 24 Jan 2024

A new chapter in cell therapy: engineered B cells reach the clinic for the first time

Cell therapy has drastically improved the scope of treatment for a number of diseases in the last few years. Now, engineered B cells are the latest approach in the field of cell therapy, having recently made it into clinical trials. But what exactly are B cells and how can they be engineered to treat diseases? […]

January 24, 2024 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 16 Jan 2024

Five biotech companies taking Florida by storm

Check out five of the top Florida companies taking the state’s biotech industry by storm with their innovative technologies.

January 16, 2024 - 6 minutesmins - By Willow Shah-Neville

Podcast 12 Jan 2024

Could natural killer cells transform Alzheimer’s treatment?

Join Dr. Paul Song, CEO of NKGen Biotech, in a podcast exploring the revolutionary use of NK cells for Alzheimer’s treatment.

January 12, 2024

Best in Biotech 11 Jan 2024

Ten NK cell therapy companies to look out for this year

As biotechs raise funding to advance their NK cell therapy candidates in the clinic, here are ten companies in the space to watch out for.

January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 19 Dec 2023

Nine biotech companies to watch in 2024

2024 is shaping up to be an exciting year for the industry. Discover nine biotech companies to keep an eye on in 2024.

December 19, 2023 - 12 minutesmins - By Jules Adam

Shutterstock 657615100 heart surgery repair

Podcast 10 Nov 2023

How biotech can mend a broken heart

CellProthera has been working to do the impossible – mend broken hearts. The biotech company’s ProtheraCytes cell therapy regenerates damaged tissue following a heart attack, thus restoring cardiac function. In this podcast, we investigate regenerative therapy with CellProthera’s CEO, Matthieu de Kalbermatten. While regenerative cell therapy is dependent on the patient’s own cells, and reliant […]

November 10, 2023

Podcast 27 Oct 2023

Beyond Biotech podcast 69 – improving access to cell and gene therapy

This week, our guest on the podcast is Jason C. Foster, CEO of Ori Biotech. Ori is a London, U.K. and New Jersey, U.S. based manufacturing technology company pioneering flexible process discovery with translation and scalable commercialization of cell and gene therapies (CGT), increasing access to these innovative treatments. Ori has developed a proprietary, full […]

October 27, 2023

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Riding on the success of CAR-T cell therapy, a breakthrough in the treatment of blood cancers, CAR-NK therapies are an emerging field in therapeutic research that aim to boost an even stronger immune response against cancer. What is CAR-NK cell therapy? Natural killer (NK) cells, like T cells, are white blood cells that are a […]

October 4, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 27 Jul 2023

Cell and gene therapy manufacturing: trends, advancements and challenges

Cell and gene therapy manufacturing has been a pertinent topic for a while now, largely due to the fact it is such a complicated process, involving a number of moving parts and excessive costs. As such, figuring out how to make these types of therapies scalable, less time consuming and cost-effective is still an ongoing […]

July 27, 2023 - 7 minutesmins - By Willow Shah-Neville

Podcast 14 Jul 2023

Beyond Biotech podcast 54

1:24 Labiotech news3:45 TolerogenixX This week, we have a conversation with Matthias Schaier, CEO of TolerogenixX, about tackling rejection of organs following transplantation. TolerogenixX GmbH, a biopharmaceutical company developing personalized cellular therapies aimed at achieving sustained immune tolerance to combat organ rejection and autoimmune diseases, has announced that its phase IIb study in renal transplant […]

July 14, 2023

News and Trends 11 Jul 2023

NK:IO awarded £1.6M grant to develop NK cell therapy

NK:IO, a U.K. company working on natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumors, has been awarded £1.6 million ($2.1 million) in grant funding from Innovate UK’s New Cancer Therapeutics program. The funding will support preclinical development, including development of a manufacturing process in collaboration […]

July 11, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 7 Jul 2023

TolerogenixX expands trial and closes €12M financing

TolerogenixX GmbH, a biopharmaceutical company developing personalized cellular therapies aimed at achieving sustained immune tolerance to combat organ rejection and autoimmune diseases, has announced that its phase IIb study in renal transplant patients has received the green light to initiate the B arm of the study. This arm consists of patients receiving minimal immune suppression […]

July 7, 2023 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cell therapy

A new chapter in cell therapy: engineered B cells reach the clinic for the first time

Five biotech companies taking Florida by storm

Could natural killer cells transform Alzheimer’s treatment?

Ten NK cell therapy companies to look out for this year

Nine biotech companies to watch in 2024

How biotech can mend a broken heart

Beyond Biotech podcast 69 – improving access to cell and gene therapy

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Cell and gene therapy manufacturing: trends, advancements and challenges

Beyond Biotech podcast 54

NK:IO awarded £1.6M grant to develop NK cell therapy

TolerogenixX expands trial and closes €12M financing

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!